Secondhand smoke exposure and intermittent claudication: a Scotland-wide study
METHODS: We conducted a cross-sectional study using the Scottish Health Surveys undertaken between 1998 and 2010. Inclusion was restricted to participants aged >45 years. Multivariate logistic regression analyses were used to adjust for potential confounders.
RESULTS: Of the 4,231 confirmed non-smokers (self-reported non-smokers with salivary cotinine concentrations <15 ng/mL), 134 (3.2%) had IC based on the Edinburgh Claudication Questionnaire. There was evidence of a dose relationship, whereby the risk of IC increased with increasing cotinine concentration. Following adjustment for potential confounders, participants with a cotinine concentration ≥2.7 ng/mL were still significantly more likely to have IC (OR 1.76, 95% CI 1.04- 3.00, p=0.036) compared with those with a cotinine concentration <0.7 mg/mL. Among non-smokers, 5.6% (95% CI -0.8%-11.7%) of cases of IC were attributable to cotinine concentrations ≥2.7 ng/mL and a further 3.6% (95% CI -6.6%-12.8%) to cotinine concentrations of 0.7-2.6 ng/mL.
CONCLUSIONS: As with coronary heart disease and stroke, SHS exposure was independently associated with IC. Our findings add to the published evidence in support of protecting the general public from SHS exposure.